ATE342064T1 - Verwendung von humanem wachstumshormon zur vermehrung der anzahl zirkulierender cd34+ zellen,zur wiederherstellung des hämapoietischen- und des immunsystems nach myeloablativer oder antiblastischer therapie, bei transplantation oder re-infusion - Google Patents
Verwendung von humanem wachstumshormon zur vermehrung der anzahl zirkulierender cd34+ zellen,zur wiederherstellung des hämapoietischen- und des immunsystems nach myeloablativer oder antiblastischer therapie, bei transplantation oder re-infusionInfo
- Publication number
- ATE342064T1 ATE342064T1 AT99965579T AT99965579T ATE342064T1 AT E342064 T1 ATE342064 T1 AT E342064T1 AT 99965579 T AT99965579 T AT 99965579T AT 99965579 T AT99965579 T AT 99965579T AT E342064 T1 ATE342064 T1 AT E342064T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- growth hormone
- antiblastic
- hemapoietic
- myeloablative
- Prior art date
Links
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 title abstract 3
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 title abstract 3
- 102000002265 Human Growth Hormone Human genes 0.000 title abstract 2
- 108010000521 Human Growth Hormone Proteins 0.000 title abstract 2
- 239000000854 Human Growth Hormone Substances 0.000 title abstract 2
- 230000002634 anti-blastic effect Effects 0.000 title 1
- 210000000987 immune system Anatomy 0.000 title 1
- 238000001802 infusion Methods 0.000 title 1
- 230000001400 myeloablative effect Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 238000002054 transplantation Methods 0.000 title 1
- 230000003394 haemopoietic effect Effects 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98124834A EP1016413A1 (en) | 1998-12-30 | 1998-12-30 | Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE342064T1 true ATE342064T1 (de) | 2006-11-15 |
Family
ID=8233268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99965579T ATE342064T1 (de) | 1998-12-30 | 1999-12-30 | Verwendung von humanem wachstumshormon zur vermehrung der anzahl zirkulierender cd34+ zellen,zur wiederherstellung des hämapoietischen- und des immunsystems nach myeloablativer oder antiblastischer therapie, bei transplantation oder re-infusion |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20060029581A1 (https=) |
| EP (3) | EP1016413A1 (https=) |
| JP (1) | JP4808316B2 (https=) |
| AT (1) | ATE342064T1 (https=) |
| AU (2) | AU772222B2 (https=) |
| BR (1) | BR9916726A (https=) |
| CA (1) | CA2354194A1 (https=) |
| CY (1) | CY1107603T1 (https=) |
| DE (1) | DE69933581T2 (https=) |
| DK (1) | DK1140149T3 (https=) |
| ES (1) | ES2275359T3 (https=) |
| IL (2) | IL143994A0 (https=) |
| PT (1) | PT1140149E (https=) |
| SI (1) | SI1140149T1 (https=) |
| WO (1) | WO2000040260A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003535144A (ja) * | 2000-06-07 | 2003-11-25 | アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ | 多能性造血幹細胞の流動を刺激するヒト成長ホルモン |
| CA2417356A1 (en) | 2000-08-01 | 2002-02-07 | Yissum Research Development Company | Directed differentiation of embryonic cells |
| ES2380009T3 (es) * | 2001-07-31 | 2012-05-07 | Genzyme Global S.A.R.L. | Métodos para movilizar las células madre/progenitoras |
| CA2540529C (en) * | 2003-10-03 | 2012-03-13 | Vib Vzw | Means and methods for the recruitment and identification of stem cells |
| JP2005289837A (ja) * | 2004-03-31 | 2005-10-20 | Juntendo | 骨髄細胞誘導剤の製造方法及び製造装置 |
| US7816320B2 (en) * | 2004-12-22 | 2010-10-19 | Ambrx, Inc. | Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35 |
| JP2013515081A (ja) * | 2009-12-21 | 2013-05-02 | アンブルックス，インコーポレイテッド | 修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5649904A (en) * | 1988-10-07 | 1997-07-22 | Sandoz Ltd. | Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both |
| US5199942A (en) * | 1991-06-07 | 1993-04-06 | Immunex Corporation | Method for improving autologous transplantation |
| EP0563485A1 (en) * | 1992-03-30 | 1993-10-06 | Schering-Plough | In vitro generation of human dendritic cells and uses thereof |
| DE69430059T2 (de) * | 1993-06-15 | 2002-11-14 | British Biotech Pharmaceuticals Ltd., Cowley | Freisetzung und Mobilisierung hämatopoietischer Zellen |
| JPH07101877A (ja) * | 1993-10-04 | 1995-04-18 | Mitsui Toatsu Chem Inc | 血小板減少症治療剤 |
| DE69433967D1 (de) * | 1993-10-06 | 2004-09-30 | Univ Florida | Stammzellen-proliferations-faktor |
| JPH0892001A (ja) * | 1994-09-26 | 1996-04-09 | Asahi Medical Co Ltd | 細胞集団の保存方法 |
| EP0871458B1 (en) * | 1995-07-21 | 2002-11-20 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
| EP0877795A4 (en) * | 1996-01-16 | 2003-03-05 | Depuy Orthopaedics Inc | INSULATION OF PROCUREMENT CELLS FROM HEMATOPOIETIC AND NON-HEMATOPOIETIC TISSUES AND THEIR USE |
| JP4042925B2 (ja) * | 1996-11-20 | 2008-02-06 | シスメックス株式会社 | 幼若白血球の分類計数法 |
| JPH10295369A (ja) * | 1997-02-26 | 1998-11-10 | Japan Tobacco Inc | 造血幹細胞の製造方法 |
| SE9804064D0 (sv) * | 1998-11-25 | 1998-11-25 | A & Science Invest Ab | Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| DE69919969T2 (de) * | 1998-12-17 | 2005-09-29 | Applied Research Systems Ars Holding N.V. | Humanes Wachstumshormon zur Stimulierung der Hämatopoese und der Immunrekonstitution nach hämatopoetischer Stammzelltransplantation beim Menschen |
| JP2003535144A (ja) * | 2000-06-07 | 2003-11-25 | アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ | 多能性造血幹細胞の流動を刺激するヒト成長ホルモン |
| US7220407B2 (en) * | 2003-10-27 | 2007-05-22 | Amgen Inc. | G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
-
1998
- 1998-12-30 EP EP98124834A patent/EP1016413A1/en not_active Withdrawn
-
1999
- 1999-12-30 WO PCT/EP1999/010470 patent/WO2000040260A1/en not_active Ceased
- 1999-12-30 DK DK99965579T patent/DK1140149T3/da active
- 1999-12-30 PT PT99965579T patent/PT1140149E/pt unknown
- 1999-12-30 IL IL14399499A patent/IL143994A0/xx unknown
- 1999-12-30 SI SI9930937T patent/SI1140149T1/sl unknown
- 1999-12-30 JP JP2000592015A patent/JP4808316B2/ja not_active Expired - Fee Related
- 1999-12-30 AT AT99965579T patent/ATE342064T1/de active
- 1999-12-30 ES ES99965579T patent/ES2275359T3/es not_active Expired - Lifetime
- 1999-12-30 EP EP06021178A patent/EP1779865A1/en not_active Withdrawn
- 1999-12-30 DE DE69933581T patent/DE69933581T2/de not_active Expired - Lifetime
- 1999-12-30 CA CA002354194A patent/CA2354194A1/en not_active Abandoned
- 1999-12-30 AU AU21039/00A patent/AU772222B2/en not_active Ceased
- 1999-12-30 BR BR9916726-3A patent/BR9916726A/pt not_active Application Discontinuation
- 1999-12-30 EP EP99965579A patent/EP1140149B1/en not_active Expired - Lifetime
-
2001
- 2001-06-26 IL IL143994A patent/IL143994A/en not_active IP Right Cessation
-
2004
- 2004-07-22 AU AU2004203355A patent/AU2004203355B2/en not_active Ceased
-
2005
- 2005-09-29 US US11/237,876 patent/US20060029581A1/en not_active Abandoned
-
2007
- 2007-01-08 CY CY20071100021T patent/CY1107603T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000040260A1 (en) | 2000-07-13 |
| AU2103900A (en) | 2000-07-24 |
| JP2002534393A (ja) | 2002-10-15 |
| US20060029581A1 (en) | 2006-02-09 |
| JP4808316B2 (ja) | 2011-11-02 |
| IL143994A0 (en) | 2002-04-21 |
| DE69933581T2 (de) | 2007-06-21 |
| AU2004203355B2 (en) | 2007-05-17 |
| EP1140149B1 (en) | 2006-10-11 |
| AU772222B2 (en) | 2004-04-22 |
| EP1779865A1 (en) | 2007-05-02 |
| EP1016413A1 (en) | 2000-07-05 |
| SI1140149T1 (sl) | 2007-02-28 |
| DK1140149T3 (da) | 2007-02-19 |
| IL143994A (en) | 2009-06-15 |
| CY1107603T1 (el) | 2013-03-13 |
| AU2004203355A1 (en) | 2004-08-19 |
| DE69933581D1 (de) | 2006-11-23 |
| EP1140149A1 (en) | 2001-10-10 |
| BR9916726A (pt) | 2001-09-11 |
| CA2354194A1 (en) | 2000-07-13 |
| PT1140149E (pt) | 2007-01-31 |
| ES2275359T3 (es) | 2007-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO844579L (no) | Enzymresistente immunomodulerende peptider. | |
| ES2112860T3 (es) | Inmunoterapia adoptiva con interleukina-7. | |
| ZA891818B (en) | Composition inducing a binding | |
| DE69329779D1 (de) | Verfahren zur behandlung geschädigter und verminderter zellen | |
| ATE348876T1 (de) | Verfahren zur vermehrung von natürlichen killerzellen | |
| ATE444078T1 (de) | Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen | |
| ATE342064T1 (de) | Verwendung von humanem wachstumshormon zur vermehrung der anzahl zirkulierender cd34+ zellen,zur wiederherstellung des hämapoietischen- und des immunsystems nach myeloablativer oder antiblastischer therapie, bei transplantation oder re-infusion | |
| DE69634982D1 (de) | Verfahren zur steigerung von hematopoietischen zellen | |
| ATE290789T1 (de) | Verwendungsmethoden von einkernigen phagozyten zur förderung der axonalen regeneration | |
| DE69231093D1 (de) | Verwendung einer zellulären Zusammensetzung zur Behandlung von menschlichen oder tierischen Organismen | |
| DE69408244D1 (de) | Vitamin D3-Analoge | |
| ATE210989T1 (de) | Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung | |
| ES8800139A2 (es) | Mejoras introducidas en el objeto de la patente principal por un procedimiento para la preparacion de derivados de urea. | |
| DE69433851D1 (de) | Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv | |
| ATE263833T1 (de) | Verwendung von dendritischen zellen-depletierten zusammensetzungen zur verbesserung der transplantation von allogenen hämatopoietischen zellen | |
| MOKASHI et al. | Identification of Optimal Conditions for Developing an Effective and Commercially Viable Biologic Product for Human Use out of Dental Pulp Stem Cell Conditioned Medium | |
| IT1172584B (it) | Metodo per la protezione biologica degli innesti delle piante, in specie del castagno, con microorganismi antagonisti | |
| UA10130A (uk) | Спосіб стимулювання проліферативної активності клітин кісткового мозку у летально опромінених тварин | |
| EP0321709A3 (en) | Fast healing and binding chemical compound or curative agent for healing wounded live animal and human soft tissues inflicted by cutting edges or separating forces | |
| ATE55411T1 (de) | Menschliches antithrombin iii, dns sequenzen dafuer, expressions- und klonierungsvektoren die solche sequenzen enthalten und damit transformierte zellkulturen, verfahren zur expression von menschlichem antithrombin iii und diese enthaltende pharmazeutische zusammensetzungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1140149 Country of ref document: EP |
|
| EEFA | Change of the company name |